Position in GILD
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$6,125,468
-$694,324 QoQ
Shares Held
48,484
-0.9% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
1.27%
of 13F equity value
Holder Rank
#533
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AUGUSTINE ASSET MANAGEMENT INC holds $23,866,482 across 7 Drug Manufacturers - General names. GILD ranks #2 (25.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
72,655 | $9,336,167 | |
| 2 | GILD |
Gilead Sciences, Inc.
This page
|
48,484 | $6,125,468 | |
| 3 | AMGN |
Amgen Inc
|
6,890 | $2,495,006 | |
| 4 | SNY |
Sanofi
|
44,133 | $1,882,713 | |
| 5 | NVO |
Novo Nordisk A S
|
34,042 | $1,631,973 | |
| 6 | LLY |
ELI LILLY & Co
|
1,270 | $1,523,276 | |
| 7 | JNJ |
Johnson & Johnson
|
3,433 | $871,879 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,125,468 | 48,484 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $6,819,792 | 48,933 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $6,005,913 | 48,932 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $5,452,209 | 49,119 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $5,465,114 | 49,293 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $5,460,532 | 48,733 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $4,789,015 | 51,846 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $4,467,162 | 53,282 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $3,637,221 | 53,013 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $3,863,351 | 52,742 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $4,309,732 | 53,200 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $3,828,684 | 51,090 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,045,096 | 52,486 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $4,353,850 | 52,475 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $4,534,339 | 52,817 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $3,331,383 | 54,002 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $3,213,563 | 51,991 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $3,359,519 | 56,510 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $4,095,494 | 56,404 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $3,947,293 | 56,511 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $3,905,394 | 56,715 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $3,800,567 | 58,805 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $3,432,154 | 58,911 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $3,969,343 | 62,816 | Shares | Sole | 2020-10-21 | |
| 2020-06-30 | $5,078,809 | 66,010 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $4,956,737 | 66,302 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||